NCT04885595 (Cryo-Nodule) is a NA clinical trial of Forceps biopsy and cryobiopsy in Lung; Node, sponsored by University of Zurich.

Who is sponsoring NCT04885595?

NCT04885595 is sponsored by University of Zurich.

What drugs are being tested in NCT04885595?

Interventions in NCT04885595: Forceps biopsy and cryobiopsy.

What condition does NCT04885595 study?

NCT04885595 studies Lung; Node.

Is NCT04885595 still recruiting?

NCT04885595 is currently completed. Last updated 28 June 2024.

Last reviewed 2024-06-28 · How we verify

NCT04885595: Cryo-Nodule

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diagnosis of Peripheral Lung Nodules Using Cryobiopsy

Completed NA Last updated 28 June 2024

What this trial tests

NA trial testing Forceps biopsy and cryobiopsy in Lung; Node in 54 participants. Completed in 30 May 2023.

Timeline

1 April 2021

Primary endpoint
15 April 2023

30 May 2023

Quick facts

Lead sponsor	University of Zurich
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	diagnostic
Enrollment	54
Start date	1 April 2021
Primary completion	15 April 2023
Estimated completion	30 May 2023
Sites	1 location across Switzerland

Drugs / interventions tested

Forceps biopsy and cryobiopsy

Conditions studied

Lung; Node — all drugs for Lung; Node →

Sponsor

University of Zurich

Who can join

Adults 18 to 90, any sex, with Lung; Node. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Since the traditional radial endobronchial ultrasound guided biopsy technique of solitary pulmonary nodules using the forceps has several shortcomings, the purpose of this study is to investigate a new biopsy technique using the transbronchial cryobrobe

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Lung; Node

Currently open trials in the same condition.

NCT05463796 — InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer · recruiting
NCT06653478 — Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagn · recruiting
NCT04734145 — Using e-Nose Technology to Identify Early Lung Cancer · active not recruiting

Other University of Zurich trials

Trials by the same sponsor.

NCT07485699 — Soy Processing and Food Allergy · NA · not yet recruiting
NCT07516912 — Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland · not yet recruiting
NCT07473115 — Individualized Analgesia in the Intensive Care Unit With a New Pain Assessment Bundle and Protocolized Analgesia Adjustm · not yet recruiting
NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
NCT06481982 — Value of Advanced MRI Techniques in the Assessment of Endometriosis · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04885595 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Zurich
Last refreshed: 28 June 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04885595.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing